![Mark Lackner](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Lackner
Inga fler pågående positioner
Förmögenhet: 779 260 $ per 2026-08-31
Profil
Mark Lackner worked at Genentech, Inc. from 2012 to 2018, serving as Director from 2015 to 2018.
From 2018 to 2022, worked at IDEAYA Biosciences, Inc. as SVP, Head-Biology & Translational Sciences.
From 2022 to 2025, worked at Zentalis Pharmaceuticals, Inc. as Chief Scientific Officer from 2023 to 2025.
Education includes a doctorate from Stanford University conferred in 1997, an undergraduate degree from the University of Illinois At Urbana–Champaign in 1990, and a graduate degree from the same institution in 1991.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-04-20 | 207 250 ( 0,22 % ) | 779 260 $ | 2026-08-31 |
Tidigare kända positioner av Mark Lackner
| Företag | Position | Slut |
|---|---|---|
| ZENTALIS PHARMACEUTICALS, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2025-04-01 |
| IDEAYA BIOSCIENCES, INC. | Företagsledare/Principal | 2022-10-01 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Direktör/Styrelseledamot | 2018-05-01 |
Mark Lackners utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
96
Första gradens relationer
5
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IDEAYA Biosciences, Inc.
 IDEAYA Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as oncology-focused precision medicine company which develops and sells cancer therapeutics | Health Technology |
University of Illinois At Urbana–Champaign
 University of Illinois At Urbana–Champaign Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Zentalis Pharmaceuticals, Inc.
 Zentalis Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops clinical therapeutics for targeting fundamental cancer pathways | Health Technology |
